<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD><!-- PageID 6028 - generated by RedDot 5.5 - 5.5.1.5 - k-dbm -->
<title>Guideline 137</title>
<meta name="description" content="Guideline 137">
<meta name="keywords" content="guideline 137, guideline 137, medicated feeds, cvm veterinary, type c, analytical methods, fda, new animal drugs, final guidance"> 
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<link href="/cvm/news.css" rel="stylesheet" type="text/css">
</HEAD>
<BODY bgcolor="#FFFFFF">
<tr> 
          <td height=68 valign="top"><img src="/cvm/Images/fda_cvm_02.gif" alt="Center for Veterinary Medicine" width="729" height="68" border="0" usemap="#MapHeader" href="/cvm/default.html"></td>
        </tr>
        <tr> 
          <td height="28"> 
            <table cellspacing=0 cellpadding=0 width="100%">
              <tbody> 
              <tr> 
                <td height="43" colspan=5> 
                  <div align="center"><!--
<span class="header"> | </span><!-- --><a href="http://www.fda.gov/default.htm" class="header">FDA Home Page</a>
<span class="header"> | </span><!-- --><a href="/cvm/default.html" class="header">CVM Home Page</a>
<span class="header"> | </span><!-- --><a href="/cvm/index.html" class="header">CVM A-Z Index</a>
<span class="header"> | </span><!-- --><a href="/cvm/contactCVM.html" class="header">Contact CVM</a>
<span class="header"> | </span><!-- --><a href="/cvm/sitemap.html" class="header">Site Map</a>
<span class="header"> | </span><!-- --><a href="http://www.fda.gov/centennial" class="header">FDA Centennial</a>
<!-- --><br>
                          <br>
                          </span><img height=1 alt="horizonal rule" 
                  src="/cvm/Images/blkpixel.gif" width="100%" 
              border=0></div>
                </td>
              </tr>
              </tbody> 
            </table>
          </td>
        </tr>
        <tr> 
          <td valign=center align=middle bgcolor=#ffffff 
            height=5><img height=5 alt="Spacer" src="/cvm/Images/dot_clear.gif" 
            width="100%" border=0></td>
        </tr>
<map name="MapHeader">
  <area shape="rect" coords="24,12,94,46" href="http://www.fda.gov" alt="FDA Logo links to FDA home page">
  <area shape="rect" coords="599,11,704,46" href="http://www.hhs.gov" alt="HHS Logo links to Department of Health and Human Services website">
  <area shape="rect" coords="167,12,557,44" href="http://www.fda.gov" alt="U.S. Food and Drug Administration">
  <area shape="rect" coords="230,54,492,66" href="/cvm/default.html" alt="Center for Veterinary Medicine">
</map>



<!-- #BeginEditable "begintext" --> 
    <p><b>Guideline No. 137</b></p>
    <div align="left"> 
      <p><b><span style="text-transform: uppercase">Guidance for Industry -Analytical Methods Description for Type C Medicated Feeds</span></b>
</p>
      
  <p>U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES<br>
    FOOD AND DRUG ADMINISTRATION<br>
    CENTER FOR VETERINARY MEDICINE<br>
  </p>
  <p><P class=Section1 align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 18pt; mso-bidi-font-size: 10.0pt"><SPAN style="mso-tab-count: 10">&nbsp;&nbsp;&nbsp;<FONT size=3><EM>Contains Non binding Recommendations</EM></FONT>&nbsp;&nbsp;&nbsp;&nbsp;</SPAN></SPAN></B></P>
<P class=Section1 align=left><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 18pt; mso-bidi-font-size: 10.0pt"><SPAN style="mso-tab-count: 10"></SPAN></SPAN></B><SPAN style="FONT-SIZE: 16pt"><FONT size=3>May 8, 2007</FONT></SPAN></P>
<P class=Section1 align=center><SPAN style="FONT-SIZE: 16pt">Guidance for Industry</SPAN></<P> 
<P class=Section1 align=center><SPAN style="FONT-SIZE: 14pt">Analytical Methods Description for Type C&nbsp;</SPAN><SPAN style="FONT-SIZE: 14pt">Medicated Feeds</SPAN></P>
<P class=Section1 align=center><SPAN style="FONT-SIZE: 14pt">Final Guidance</SPAN></P>
<P class=Section1>&nbsp;</P>
<DIV class=Section1>
<P>Comments and suggestions regarding this&nbsp;guidance should be sent to the Division of Dockets Management (HFA-305), Food and Drug Administration, <?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /><st1:Street w:st="on"><st1:address style="BACKGROUND-POSITION: left bottom; BACKGROUND-IMAGE: url(res://ietag.dll/#34/#1001); BACKGROUND-REPEAT: repeat-x" tabIndex=0 w:st="on">5630 Fishers Lane</st1:address></st1:Street>, Room 1061, <st1:place w:st="on"><st1:City w:st="on">Rockville</st1:City>, <st1:State w:st="on">MD</st1:State><SPAN style="mso-spacerun: yes">&nbsp; </SPAN><st1:PostalCode w:st="on">20852</st1:PostalCode></st1:place>.<SPAN style="mso-spacerun: yes">&nbsp;&nbsp;</SPAN><SPAN style="mso-spacerun: yes"> S</SPAN>ubmit electronic comments to&nbsp;<A href="http://www.fda.gov/dockets/ecomments">http://www.fda.gov/dockets/ecomments</A>.&nbsp; All comments should be identified with the Docket No.&nbsp; 2006D-0254. </P>
<P>For questions regarding this guidance document, contact Rebecca L. Owen, Center for Veterinary Medicine (HFV-141), Food and Drug Administration, 7500 Standish Place, Rockville, MD<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>20855, 240-276-9842, E-mail: <A href="mailto:rebecca.owen@fda.hhs.gov">rebecca.owen@fda.hhs.gov</A>.</P>
<P>Additional copies of this guidance document may be requested from the Communications Staff (HFV-12), Center for Veterinary Medicine, Food and Drug Administration, <st1:address style="BACKGROUND-POSITION: left bottom; BACKGROUND-IMAGE: url(res://ietag.dll/#34/#1001); BACKGROUND-REPEAT: repeat-x" tabIndex=0 w:st="on"><st1:Street w:st="on">7519 Standish Place</st1:Street>, <st1:City w:st="on">Rockville</st1:City>, <st1:State w:st="on">MD</st1:State><SPAN style="mso-spacerun: yes">&nbsp; </SPAN><st1:PostalCode w:st="on">20855</st1:PostalCode></st1:address>, and may be viewed on the Internet at <A href="http://www.fda.gov/cvm">http://www.fda.gov/cvm</A>.</P></DIV>
<DIV class=Section1>
<P align=center><SPAN style="mso-bidi-font-size: 12.0pt">&nbsp;</P></SPAN>
<P><B style="mso-bidi-font-weight: normal">TABLE OF CONTENTS</B></P>
<P><B style="mso-bidi-font-weight: normal"></B>&nbsp;</P>
<DIV style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 1pt; BORDER-LEFT: medium none; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid; mso-element: para-border-div; mso-border-bottom-alt: solid windowtext .75pt">
<P><SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Page No.</P></DIV>
<P><B style="mso-bidi-font-weight: normal"></B>&nbsp;</P>
<P>I.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Introduction<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>3</P>
<P>II. Discussion<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>4</P>
<P>A.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Title of the Method<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>5</P>
<P>B.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Scope and Field of Application<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>5</P>
<P>C.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Principle <SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>5</P>
<P>D.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Definitions<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>6</P>
<P>E.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Warnings and Safety Precautions<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>6</P>
<P>F.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Reagents and Chemicals<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>6</P>
<P>G.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Equipment and Apparatus<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>6</P>
<P>H.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Solutions<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>8</P>
<P>I.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Standards/Reference Materials<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>8</P>
<P>J.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Sampling and Sample Handling<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>9</P>
<P>K.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Preparing Samples for Analysis<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>9</P>
<P>L.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Instrumental Analysis of Samples<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>11</P>
<P>M.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Calculating and Expressing Results<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>12</P>
<P>N.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Data Acceptability Criteria<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>13</P>
<P>O.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Figures and Tables<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>14</P>
<P>P.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>References<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>15</P>
<P>Q.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Appendices<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>15</P>
<P>&nbsp;</P><SPAN style="FONT-SIZE: 22pt; FONT-FAMILY: 'Times New Roman'; mso-bidi-font-size: 10.0pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"><BR style="PAGE-BREAK-BEFORE: always" clear=all></SPAN>
<P align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 14pt; mso-bidi-font-size: 10.0pt">Guidance for Industry</SPAN></B></<P> 
<P align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 14pt; mso-bidi-font-size: 10.0pt">Analytical Methods Description for Type C Medicated Feeds</SPAN></B></P>
<P align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 14pt; mso-bidi-font-size: 10.0pt">Final Guidance<A style="mso-footnote-id: ftn1" href="#[1]" name=_ftnref1><SPAN style="mso-special-character: footnote"><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; mso-bidi-font-size: 10.0pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[1]</SPAN></B></SPAN></A></A></SPAN></B></P>
<P>&nbsp;</P>
<DIV style="BORDER-RIGHT: windowtext 3pt solid; PADDING-RIGHT: 4pt; BORDER-TOP: windowtext 3pt solid; PADDING-LEFT: 4pt; PADDING-BOTTOM: 1pt; BORDER-LEFT: windowtext 3pt solid; PADDING-TOP: 1pt; BORDER-BOTTOM: windowtext 3pt solid; mso-element: para-border-div">
<P class=box style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; PADDING-TOP: 0in; BORDER-BOTTOM: medium none; mso-border-alt: solid windowtext 3.0pt; mso-padding-alt: 1.0pt 4.0pt 1.0pt 4.0pt"><SPAN style="FONT-SIZE: 12pt">This guidance&nbsp;represents the Food and Drug Administration's (FDA's) current thinking on this topic.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>It does not create or confer any rights for or on any person and does not operate to bind FDA or the public.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You can use an alternative approach if the approach satisfies the requirements of applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If you cannot identify the appropriate FDA staff, call the telephone number listed on the title page of this guidance.</SPAN></P></DIV>
<P>&nbsp;</P>
<P><B style="mso-bidi-font-weight: normal">I.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Introduction</B></P>
<P>This&nbsp;guidance provides our (the Office of New Animal Drug Evaluation, Center for Veterinary Medicine) recommendations for describing methods for analyzing new animal drugs in Type C medicated feeds.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This&nbsp;guidance applies to instrumental methods only (e.g., High Pressure Liquid Chromatography (HPLC), Gas Chromatography (GC)).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For information on other methods (e.g., microbiological methods) you should contact us.</P>
<P>Section 512 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. &sect; 360b) establishes the requirements for new animal drug approval.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>FDA regulations specify the information you must submit as part of your new animal drug application (NADA) and the proper format for the NADA submission.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>21 CFR Part 514.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>As part of your NADA submission, you must include a “detailed description of the collection of samples and the analytical procedures to which they are subjected.”<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>21 CFR &sect; 514.1(b)(5)(vii).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This should include a description of practicable methods of analysis that have adequate sensitivity to determine the amount of the new animal drug in the final dosage form.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>21 CFR &sect; 514.1(b)(5)(vii)(<I style="mso-bidi-font-style: normal">a</I>).</P>
<P><B><I><SPAN style="mso-bidi-font-size: 12.0pt">FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word "should" in Agency guidances means that something is suggested or recommended, but not required.</SPAN></I></B><B style="mso-bidi-font-weight: normal"></B></P>
<P><B style="mso-bidi-font-weight: normal">II. Discussion</B></P>
<P>This&nbsp;guidance includes recommendations to help you describe the methods used to analyze drug(s) in Type C medicated feeds manufactured with Type A medicated articles.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Throughout this guidance, we have included examples of items we recommend you include in your method description.</P>
<P>You should include sufficient detail in your description to ensure a clear understanding of the operational procedures.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We encourage you to include notes in your description to elaborate upon specific procedures or steps, or to provide recommendations about what to do when an unexpected circumstance occurs.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend that you highlight these notes in your description document (e.g., capitalized, bolded, italicized) to emphasize this information.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Your description should enable an analyst to perform the test method in its entirety.</P>
<P>The following represent the most common sections of a method used to analyze drugs.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend that you organize your description, when possible, under the categories listed.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>However, not all of the sections we have listed will apply to every method description.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Thus, you should include only the appropriate sections in your method description.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>In general, these sections are:</P>
<P>A.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Title of the Method</P>
<P>B.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Scope and Field of Application </P>
<P>C.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Principle</P>
<P>D.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Definitions</P>
<P>E.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Warning and Safety Precautions</P>
<P>F.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Reagents and Chemicals</P>
<P>G.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Equipment and Apparatus</P>
<P>H.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Solutions</P>
<P>I.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Standards/Reference Materials</P>
<P>J.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Sampling and Sample Handling</P>
<P>K.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Preparing Samples for Analysis</P>
<P>L.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Instrument Analysis of Samples</P>
<P>M.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Calculating and Expressing Results</P>
<P>N.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Data Acceptability Criteria</P>
<P>O.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Figures and Tables</P>
<P>P.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>References</P>
<P>Q.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Appendices<B style="mso-bidi-font-weight: normal"></B></P>
<P>&nbsp;</P>
<P>We recommend that you include a header with appropriate identification information such as a brief title, method version number, and company/sponsor name on each page of your method description.<I style="mso-bidi-font-style: normal"></I></P>
<P>&nbsp;</P>
<P><B style="mso-bidi-font-weight: normal">A.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>TITLE OF THE METHOD</B></P>
<P>This section of the method description should include the drug, feed type (e.g., mash, pellets), and type of analysis.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN><B style="mso-bidi-font-weight: normal"></B></P>
<P><B style="mso-bidi-font-weight: normal">B.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>SCOPE AND FIELD OF APPLICATION </B></P>
<P>This section should describe the type of analytical techniques (e.g., gas chromatography with flame ionization detector, high pressure liquid chromatography with UV or fluorescence detection) for each drug of interest.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If the specific analytical procedure measures multiple chemical entities or forms of a drug, you should clearly describe the range of validated concentrations for the drug and what entity or entities were used to validate the method for each drug form (e.g., free acid, free base, sulfate salt, hydrochloride salt).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If applicable, you should describe the multiple forms of the drug as different optical or structural isomers.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If the product is a mixture, you should describe the different drug components that the method can determine.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We encourage you to develop and refer to a figure with structures of these chemical entities to provide a clear and unequivocal understanding about the drugs in the feed that the method can determine.</P>
<P>This section should also describe the applicable feed types that the method can analyze and the species that will consume the feed.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If the test method is validated for other types of feed matrices in addition to Type C complete feeds, you should list these other feed products in this section.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For example, some methods may also include instructions for the analyses of Type B medicated feeds and organic or mineral based feed matrices.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>In addition, this section (as well as other relevant sections throughout the document) should describe changes to the method necessary to analyze different types of feed (liquid or solid feeds, organic- or mineral-based feeds) or in the presence or absence of specific inactive components or carriers in the feed sample.</P>
<P><U>Interference testing</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Your should indicate which compounds you tested for possible interference, how you tested them, and what compounds, if any, could potentially cause interference.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe any specific compounds you identified that may interfere with the determination of the drug or drug components.</P>
<P><B style="mso-bidi-font-weight: normal">C.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>PRINCIPLE</B></P>
<P>This section should describe the basic steps of the test method in terms of extraction, sample clean-up, final instrument-ready steps, etc., and describe salient features.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe whether the method requires derivatization.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You may also include information on derivatization under a separate sub-heading, such as, “REACTIONS.”<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend that you<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>develop and refer to a diagram, and include it in a Figures and Tables section (see Section O, below).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P>
<P><B style="mso-bidi-font-weight: normal">D.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>DEFINITIONS</B></P>
<P>This section should define terms and abbreviations you use in your method description to ensure a complete understanding of the method.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For example, we recommend that you include a precise definition of units used in your method because units can have different meanings in different countries.</P>
<P><B style="mso-bidi-font-weight: normal">E.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>WARNINGS AND SAFETY PRECAUTIONS</B></P>
<P>This section should describe appropriate WARNING and/or CAUTION statements and specific procedures for the safe handling of hazardous chemicals and reagents.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN><B style="mso-bidi-font-weight: normal">Note:</B><SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We strongly recommend that methods not require particularly hazardous chemicals and reagents, halogenated solvents, etc., unless necessary for successful analyses.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If you believe that such materials are necessary for successful analyses, we encourage you to consult CVM during method development to discuss the use of these materials.<SPAN style="mso-spacerun: yes">&nbsp;&nbsp; </SPAN></P>
<P><B style="mso-bidi-font-weight: normal">F.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>REAGENTS AND CHEMICALS</B></P>
<P>This section should describe all of the reagents and chemicals that the method uses, including buffer salts, solvents, derivatizing agents, etc.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If critical to the method, you should also describe the grade of the chemical or solvent.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We also encourage you to include the suggested supplier and location, catalog number, etc.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For example, you may include the following information in your description of reagents and chemicals:<SPAN style="mso-spacerun: yes">&nbsp;&nbsp;</SPAN><SPAN style="mso-tab-count: 1">&nbsp;&nbsp; </SPAN><I style="mso-bidi-font-style: normal"></I></P>
<P><I style="mso-bidi-font-style: normal">Unless otherwise stated, use only reagents and chemicals of analytical grade quality and only deionized water or chromatographic grade water.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Reference to a company is for information and identification only and does not imply a recommendation unless so stated</I>.<SPAN style="FONT-STYLE: normal"><SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></P>
<P>Example chemical descriptions follow:</P>
<P><SPAN style="FONT-STYLE: normal; FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="mso-spacerun: yes">&nbsp;</SPAN>Acetonitrile:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>UV grade, Company/Vendor name and location, or equivalent, Catalog number, etc.</P>
<P><SPAN style="FONT-STYLE: normal; FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><SPAN style="mso-spacerun: yes">&nbsp;</SPAN>Citric Acid:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>AR grade, granular, Company/Vendor name and location, or equivalent, Catalog number, etc. </P>
<P><B style="mso-bidi-font-weight: normal">G.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>EQUIPMENT AND APPARATUS</B></P>
<P>This section should include a list of all of the laboratory supplies, equipment and instruments that the method requires.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If critical for proper method performance, you should describe specific information about the supplier, company location, catalog number, product (e.g., glassware type, quality or grade), etc.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe the required accuracy and precision for each piece of equipment or apparatus (e.g., pipettes, analytical balances).<A style="mso-footnote-id: ftn2" href="#[2]" name=_ftnref2><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman'; mso-bidi-font-size: 10.0pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[2]</SPAN></SPAN></A><SPAN style="mso-spacerun: yes">&nbsp;</SPAN></A><SPAN style="mso-spacerun: yes">&nbsp;&nbsp;&nbsp; </SPAN></P>
<P>You should state in your method description whether the method requires specific supplies and equipment to meet performance criteria.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If common equipment and general laboratory supplies will serve equally well, you should include a statement such as “or equivalent” when referring to equipment and laboratory supplies in your description. You may include a description of the acceptability criteria for these materials in this section, but you should also include this information in Section K. </P>
<P>You may include a disclaimer statement in this section such as:</P>
<P><I style="mso-bidi-font-style: normal">References to specific brand (company) names are for information and identification only and do not imply a recommendation unless so stated.</I></P>
<P>This section should also clearly describe the configuration of components in an instrument system, identifying each component of the analytical instrumentation individually.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe the configuration of unusual, complex, or specialized analytical instrumentation from sample introduction to data system analysis, preferably in a figure in block diagram fashion.</P>
<P>We recommend using a numbering scheme in your written method description for clarity. The numbering scheme we use in the example below is illustrative.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>A description of equipment and apparatus could include, but is not limited to, the following:</P>
<P><I style="mso-bidi-font-style: normal">G.1<SPAN style="mso-tab-count: 1">&nbsp;&nbsp; </SPAN>Equipment</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.1<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Autosampler vials: 12 </I><I style="mso-bidi-font-style: normal"><SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&acute;</SPAN></SPAN> 32 mm Borosilicate glass, crimp top, Company/Vendor name and location, or equivalent, catalog number(s), etc.</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.2<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Volumetric flask, 10 ml, Class A, Company/Vendor name and location, or equivalent, catalog number(s), etc.</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.3<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>SPE Cartridge: Name/Model, 500 mg, LRC, Company/Vendor name and location, or equivalent, catalog number(s), etc.</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>HPLC<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>system:</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4.1<SPAN style="mso-tab-count: 1">&nbsp;&nbsp; </SPAN>HPLC Pump: Quaternary gradient pump, Company/Vendor name and location, model no., or equivalent.</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4.2<SPAN style="mso-tab-count: 1">&nbsp;&nbsp; </SPAN>Injector: ..., or equivalent. </I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4.3<SPAN style="mso-spacerun: yes">&nbsp;&nbsp; </SPAN>Column:</I> <I style="mso-bidi-font-style: normal">..., or equivalent</I>.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN><I style="mso-bidi-font-style: normal">Similar columns from other vendors have not been evaluated for performance in this assay.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Therefore, no other columns can be recommended.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If other columns are tested, they should meet the system suitability criteria as described in Sections K and L.</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4.4<SPAN style="mso-tab-count: 1">&nbsp;&nbsp; </SPAN><SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Mixing Tee:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>...,<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>or equivalent.</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4.5<SPAN style="mso-spacerun: yes">&nbsp;&nbsp; </SPAN>Connecting Tubing:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>...,<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>or equivalent.</I></P>
<P><I style="mso-bidi-font-style: normal"><SPAN style="mso-spacerun: yes">&nbsp;</SPAN>G. 1.4.6<SPAN style="mso-spacerun: yes">&nbsp;&nbsp; </SPAN>In-Line Filters:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>..., or equivalent. </I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4.7<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Detector:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>..., or equivalent.</I></P>
<P><I style="mso-bidi-font-style: normal">G.1.4.8<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Data System:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>..., or equivalent.</I></P>
<P><B style="mso-bidi-font-weight: normal"></B>&nbsp;</P>
<P><B style="mso-bidi-font-weight: normal">H.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>SOLUTIONS</B></P>
<P>This section should describe, by name, each solution used in performing the method, the concentration as molarity or percent (by weight or volume), pH range, storage conditions, stability or shelf life of the solutions, and frequency of preparation (e.g., daily, weekly, monthly).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should also include the amount of the chemical or reagent that is used to prepare a set volume of the solution, along with instructions for preparing the solution.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For each solution, the description should state whether it must be prepared with extreme accuracy and precision, or whether approximate concentrations (state range of concentration, if known) will suffice.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If extreme precision is needed, you should describe specific details and equipment for preparing the solution and for performing all critical measurements.</P>
<P><st1:place w:st="on"><B style="mso-bidi-font-weight: normal">I.</B></st1:place><SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><B style="mso-bidi-font-weight: normal">STANDARDS/REFERENCE MATERIALS</B></P>
<P>This section of the method description should specify the chemical name (e.g., generic, International <st1:place w:st="on">Union</st1:place> of Pure and Applied Chemistry (IUPAC), Chemical Abstracts Service (CAS)), ID number (if applicable), source, storage conditions, and duration of storage for a Drug Substance Reference Standard (provided by sponsor) or Certified Reference Standard Material (commercial source).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For some compounds, you may list lot number and purity for the compounds.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If, however, you expect lot numbers and/or purity to change with time, we recommend that you instead refer to the Certificate of Analysis accompanying a particular compound. </P>
<P>You should provide detailed descriptions including specific steps or equipment for preparing reference standards, test solutions and any test-matrix fortification solution(s), and for performing all critical measurements.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P>
<P>To reduce the possibility of systematic errors that could occur during calculations, this section should clearly describe any corrections to concentrations of standards based on potency or purity.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>In addition, this section should describe the storage conditions and stability or shelf life of the solutions, as well as the frequency of preparation (e.g., daily, weekly, monthly).</P>
<P>&nbsp;</P>
<P><B style="mso-bidi-font-weight: normal">J.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>SAMPLING AND SAMPLE HANDLING</B></P>
<P>J.1.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Obtaining the laboratory sample (sample size)</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>The quantity of the sub-sample (weight or volume range) of the original bulk feed should provide a feed sample that is representative of the whole feed matrix.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe the sampling procedure for obtaining this test portion.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P>
<P>If a smaller sub-sample of the laboratory sample can be used for the analysis, you should describe the sub-sample weight or volume range here, and in Section K<A href="#" name=.[3]>.<A style="mso-footnote-id: ftn3" href="#[3]" name=_ftnref3><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman'; mso-bidi-font-size: 10.0pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[3]</SPAN></SPAN></A></A></P>
<P>J.2.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Sample handling procedures</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should include a description for homogenizing or grinding the sample before analysis, if necessary, and any special equipment needed to prepare the sample.</P>
<P>J.3.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Sample stability</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should include a description of the storage conditions for samples, as well as the expected shelf-life, in the event that the analyst cannot assay the feed samples immediately upon receipt, and precautionary statements about the stability of the drug in frozen matrix and the effect of freeze/thaw cycles, if known.</P>
<P><B style="mso-bidi-font-weight: normal"><SPAN style="TEXT-TRANSFORM: uppercase">K.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>PreparING Samples for Analysis</SPAN></B></P>
<P>This section should describe the information the analyst needs to ensure a complete understanding of the method and to enable the analyst to perform each procedure in its entirety.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe any specific supplies and equipment required to meet specific performance or suitability criteria for any procedure or overall performance of the method.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should also clearly describe the procedures to perform suitability tests for these materials. </P>
<P>This section should describe the procedures (e.g., liquid extraction, liquid-liquid partitioning, solid phase extraction) in the method, and all operational steps in those procedures, in sequence.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend using some type of numbering or lettering sequence. </P>
<P>You should elaborate upon special aspects of the operational steps.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe, in the appropriate sections throughout the document, any contingency actions that may apply.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Additionally, you should describe appropriate stopping places in each procedure in the event that interruptions occur, or in the event that the analyst cannot complete the entire procedure from start to finish in a given period of time.</P>
<P>This section should describe the critical control points and include special notes such as: </P>
<P><I style="mso-bidi-font-style: normal"><SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Protect from heat and light</I><SPAN style="mso-spacerun: yes">&nbsp; </SPAN>-or- </P>
<P><I style="mso-bidi-font-style: normal"><SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>Storage at temperatures &lt; 5</I><I style="mso-bidi-font-style: normal"><SUP><SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&deg;</SPAN></SPAN></SUP>C is required.</I></P>
<P>If, as part of the method, a procedure uses chemicals, solvents or equipment that could be toxic, hazardous, or represent a potentially dangerous step, you should provide a specific precautionary statement, such as:</P>
<P><I style="mso-bidi-font-style: normal">SAFETY PRECAUTION:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>The following procedure uses toxic solvent ABC.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Therefore, you should carry out procedure 10.x in an appropriately well ventilated work center.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Refer to Section E.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>(Warnings and Safety Precautions).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></I></P>
<P>We recommend you prepare and refer to a flow diagram of the method, from sample preparation through analysis, which you include in a Figures and Tables section (see Section O, below).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should also include a description of the efficiency of the method relative to productivity (e.g., number of samples processed in an 8-hour day or a 5-day week, number of samples an experienced analyst can prepare in <I style="mso-bidi-font-style: normal">x</I> hours). </P>
<P>K.1.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Test Portion</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe how to obtain the sub-sample, either by weight or volume, and the equipment you should use for this purpose.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>It should describe acceptable variance limits to the weight or volume of the sample.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For example: </P>
<P>Accurately weigh 10<SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&plusmn;</SPAN></SPAN>1 g of "thawed" feed (Section J.) to the nearest 0.01 g with an analytical balance using a 50 mL polypropylene test tube ... .</P>
<P>You may also describe whether the method includes a control/blank feed sample and a fortified control feed sample, as quality control (QC) samples, with each set of test samples or at other defined intervals, and a description of the fortification procedure<A href="#" name=.[4]>.<A style="mso-footnote-id: ftn4" href="#[4]" name=_ftnref4><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman'; mso-bidi-font-size: 10.0pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[4]</SPAN></SPAN></A></A><SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P>
<P>K.2.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Operational steps</U>: This section should include a detailed description, numbered for clarity, of the operational steps the analyst should perform, including preparing the processed sample for instrument introduction.<SPAN style="mso-spacerun: yes">&nbsp;&nbsp; </SPAN>Examples include liquid partitioning or solid phase extraction.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should include any precautionary statements.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For example:</P>
<P><I style="mso-bidi-font-style: normal">Critical Control Point:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>The flow rate should not exceed 2 mL/min at any time.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Flow-rates slower than 1 mL/min are acceptable, but do not significantly improve method performance.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></I></P>
<P>You should describe the specific procedure for diluting the sample, if necessary for performing the method.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If the sample is sensitive to light, temperature, or requires special handling, you should clearly state this information.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should also describe storage conditions, as well as the expected shelf life, in the event that the analyst cannot assay the final prepared sample immediately.</P>
<P><B style="mso-bidi-font-weight: normal">L.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><SPAN style="TEXT-TRANSFORM: uppercase">Instrument Analysis of Samples</SPAN></B></P>
<P>L.1.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Instrument System Set-Up</U>:<B style="mso-bidi-font-weight: normal"><SPAN style="mso-spacerun: yes">&nbsp; </SPAN></B>This section should describe the essential operating parameters for the instrument.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe all required parameters, specific setup instructions, and specific maintenance steps (e.g., periodic flushing of lines, equilibration time between runs, preconditioning analytical columns) in sufficient detail for the analyst to properly operate the instrument.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend that you include subheadings and precautionary notes, as appropriate, in your method description.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P>
<P>For example, for an HPLC method, the description of parameters could include, but is not limited to, information about:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>pump system, dead volume of pump system, mobile phase, gradient program, flow rate, column pre-equilibration times between runs, chromatographic column, detector type, and all other instrument settings, etc.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P>
<P>L.2.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Instrument and Equipment Suitability</U>:<B style="mso-bidi-font-weight: normal"><SPAN style="mso-spacerun: yes">&nbsp; </SPAN></B>This section should describe the suitability test(s) that helps diagnose whether instrument performance is acceptable.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe performance criteria that are required for acceptable performance.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should also describe what, if any, corrective action should be taken for unacceptable performance.</P>
<P>If specific supplies and equipment must meet minimum performance criteria before being used in the method (see Section G), you should describe in clear, well defined terms the procedure(s) and criteria to establish the suitability of materials.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>These parameters may be based upon experience gained during development or validation of the method.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN><B style="mso-bidi-font-weight: normal"></B></P>
<P>L.3.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Sample Analysis Steps</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should clearly describe any steps that are critical to the proper execution of the method.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If specific data collection or processing steps are critical for achieving acceptable performance, or if atypical procedures are needed, you should include this information in your written method description.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should also describe procedures and parameters for data acquisition, base-line correction, and peak integration.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If the drug and interfering compounds potentially have similar retention times, you should describe procedures for peak definition in sufficient detail to identify and quantitate the specific drug peak. An example follows: </P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal"><U>System Operation</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Make the HPLC operational (Section L.1).</I><I style="mso-bidi-font-style: normal"><SPAN style="mso-tab-count: 3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal"><U>Calibration Standards</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>As applicable, describe the number of standards and whether calibration requires single or multiple injections of each to generate a typical calibration curve or response factor.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Describe minimum acceptance criteria as appropriate.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal"><U>System Suitability Tests</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Describe the procedures and criteria that ensure system performance.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This description could include, but is not limited to, information on criteria such as:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>obtaining a linear calibration curve, precision of repeat injections, analyte retention times, analyte peak shape, recovery of analyte from spiked samples or quality assurance samples, lack of chromatographic interference for the analyte, etc.<SPAN style="mso-spacerun: yes">&nbsp;&nbsp; </SPAN><B style="mso-bidi-font-weight: normal">Note:</B><SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend you include a description of criteria used in the method for accepting or rejecting results from suitability tests, and a description of corrective actions to take for any unacceptable results.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal"><U>Sample Analysis</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe the steps for performing the sample analyses (sample analyses sequence).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For example:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></I></P>
<P><I style="mso-bidi-font-style: normal">Analyze samples and standards by HPLC in random order using the bracketing technique.</I></P>
<P>In addition, this section could describe the recommendations for an analysis sequence which may include, but is not limited to, analysis of check samples, other types of quality assurance samples, feed controls and blanks, etc.</P>
<P><B style="mso-bidi-font-weight: normal">M.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp; </SPAN>CALCULATING AND EXPRESSING RESULTS</B></P>
<P>M.1.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Calibration Method</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should provide a description of how to construct a standard response curve, if applicable.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>In most cases, a linear response function will be sufficient. This section should also describe the instrument data systems or non-system PC software, such as spreadsheets, used to perform the calculations. </P>
<P>M.2.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Drug Concentration</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe how to calculate the concentration of the drug in feed, and define units and other parameters of the equation.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You should describe the specific chemical entity or entities measured, and the form of the drug used in calculations, as appropriate.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Additionally, you should describe any corrections to concentrations of the standard solutions based on potency or purity in this section as well as in Section I. </P>
<P>You should include a description of the calculation used to measure the drug concentration in a sample using hypothetical data.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>For example, you could include a detailed illustration of drug recovery from a fortified control.</P>
<P>We are including example equations, below, for determining the concentration using a linear calibration line and using a single point calibration standard (single response function).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P>
<P><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Example 1</I></B><I style="mso-bidi-font-style: normal"> (calibration line):</I></P>
<P><I style="mso-bidi-font-style: normal"><SPAN style="mso-spacerun: yes">&nbsp;</SPAN>[(P<SUB>sample </SUB>– Y<SUB>intercept</SUB>) </I><I style="mso-bidi-font-style: normal"><SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&cedil;</SPAN></SPAN> slope] x [Vol<SUB>sample</SUB> </I><I style="mso-bidi-font-style: normal"><SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&cedil;</SPAN></SPAN><SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Wt<SUB>sample</SUB>] x DF </I></P>
<P><I style="mso-bidi-font-style: normal">Where:</I></P>
<P><I style="mso-bidi-font-style: normal">P<SUB>sample</SUB> = Peak Height or Peak Area for the drug,</I></P>
<P><I style="mso-bidi-font-style: normal">Y<SUB>intercept</SUB>, obtained from analysis of the standard curve,</I></P>
<P><I style="mso-bidi-font-style: normal">Slope, obtained from analysis of the standard curve.</I></P>
<P><I style="mso-bidi-font-style: normal">Vol<SUB>sample</SUB> = Final volume of the sample solution for analysis,</I></P>
<P><I style="mso-bidi-font-style: normal">Wt<SUB>sample</SUB> = Weight of feed sample analyzed or extracted</I></P>
<P><I style="mso-bidi-font-style: normal">DF =<SPAN style="mso-tab-count: 1">&nbsp;&nbsp; </SPAN>Dilution/Conversion Factor, if any, when dilutions were made in the sample preparation that changed the relationship of the final sample relative to the original feed sample or to allow conversion of units of measure.</I></P>
<P><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Example 2</I></B><I style="mso-bidi-font-style: normal"> (single point calibration):</I></P>
<P><I style="mso-bidi-font-style: normal">[ P<SUB>sample</SUB> </I><I style="mso-bidi-font-style: normal"><SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&cedil;</SPAN></SPAN> R<SUB>standard</SUB>] x [Vol<SUB>sample</SUB> </I><I style="mso-bidi-font-style: normal"><SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&cedil;</SPAN></SPAN> Wt<SUB>sample</SUB>] x DF</I></P>
<P><I style="mso-bidi-font-style: normal">Where:</I></P>
<P><I style="mso-bidi-font-style: normal">R<SUB>standard</SUB> = Response factor (peak height of standard per unit concentration).</I></P>
<P><B style="mso-bidi-font-weight: normal">N.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>DATA ACCEPTABILITY CRITERIA</B></P>
<P>This section should describe criteria for accepting or rejecting feed assay data.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>Unlike Sections G, K, and L, which describe suitability criteria for the independent performance of equipment, supplies, and instrumentation, this section should describe the cumulative aspects of these factors to interpret whether final data from a sample are acceptable.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe the corrective or contingency actions that should be taken if data are not acceptable.</P>
<P>Data acceptability criteria for samples may include procedures for initiating the method in a new laboratory (qualification) or for routine processes used during regular analyses (quality control).<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>If this section recommends conducting analyses of a blank/control feed or a blank feed spiked with drug, these control feeds should be available or you should provide information that allows the analyst to prepare these samples.</P>
<P>N.1.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Sample Analysis Evaluation</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe the criteria to evaluate the acceptability of final results from analyses.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You can base these criteria on, among other things, chromatographic performance (peak shape, resolution of drug from interfering substances, etc.), recovery of drug from fortified samples within a specified range, minimum acceptable CVs when n <SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">&sup3;</SPAN></SPAN> 3, etc.</P>
<P>N.2.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Calibration difficulties</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe the steps to take if an unknown sample falls above or below the limits of the standard curve.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This description should include directions for dilution or concentration of the final sample or re-analysis by specific procedures to bring the amount of drug injected within specified calibration limits.</P>
<P>N.3.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>System Failures</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe the steps to take, including corrective action, if analytical results are unacceptable or if system failures produce poor results.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>As appropriate, this section may describe diagnostic procedures for evaluating the cause(s) of analysis failures and procedures for corrective or contingency actions.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section may reference specific system suitability tests that were described in Sections G, K, and L. </P>
<P>N.4.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN><U>Blank/Control Results</U>:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>This section should describe criteria to evaluate the acceptability of analysis of control samples.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>You may base these criteria on, among other things, chromatographic resolution or window of noninterference.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend that you include contingency options in case problems arise.</P>
<P><B style="mso-bidi-font-weight: normal">O.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>FIGURES AND TABLES</B></P>
<P>This section should include figures and tables to aid in describing features of the method or to illustrate expected behavior of specific assays.<SPAN style="mso-spacerun: yes">&nbsp;&nbsp; </SPAN>Below is an example of figures that may accompany a HPLC method.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>These figures could include, but are not limited to:</P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">Structures of chemical entities measured in the assay. </I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">Proposed chemistry in the derivatization of the drug.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">Block diagram of the HPLC analytical system.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">Flow diagram of the sample preparation procedure.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">Representative HPLC chromatogram for the drug standard.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">Standard curve if using multiple point calibration.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">Representative HPLC chromatogram(s) for control/blank (nonfortified) feed sample(s)</I><I style="mso-bidi-font-style: normal"><SPAN style="FONT-FAMILY: Symbol; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">-</SPAN></SPAN> multiple illustrative chromatograms if you use multiple feed matrices or types of feeds.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">HPLC chromatogram for control feed fortified with drug at x g/ton.</I></P>
<P><SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN style="mso-list: Ignore">&middot;<SPAN style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><I style="mso-bidi-font-style: normal">HPLC chromatogram for an authentic feed containing drug at a concentration of x ppm (or x g/ton).</I></P>
<P><B style="mso-bidi-font-weight: normal">P. <SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>REFERENCES</B></P>
<P>This section should include a list of references, as appropriate.</P>
<P><B style="mso-bidi-font-weight: normal">Q.<SPAN style="mso-tab-count: 1">&nbsp;&nbsp;&nbsp;&nbsp; </SPAN>APPENDICES</B></P>
<P>This section should include any additional information or documents that improve the understanding of the method.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>We recommend that you provide a summary of validation data to allow analysts to compare the performance of the method in their laboratories to the originating laboratory.<BR clear=all>
<HR align=left width="33%" SIZE=1>

<P></P></DIV>
<DIV style="mso-element: footnote-list">
<DIV id=ftn1 style="mso-element: footnote">
<P><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"><A name=[1]><A style="mso-footnote-id: ftn1" href="#[1]" name=_ftn1><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[1]</SPAN></SPAN></A><A style="mso-footnote-id: ftn1" href="#[1]" name=_ftn1></A></SPAN></SPAN></A> This guidance has been prepared by the Office of New Animal Drug Evaluation in the Center for Veterinary Medicine at the Food and Drug Administration.</P></DIV>
<DIV id=ftn2 style="mso-element: footnote">
<P><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"><A name=[2]><A style="mso-footnote-id: ftn2" href="#[2]" name=_ftn2><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[2]</SPAN></SPAN></A><A style="mso-footnote-id: ftn2" href="#[2]" name=_ftn2></A></SPAN></SPAN></A> Accuracy and precision of specific equipment or apparatus may be inherent.</P></DIV>
<DIV id=ftn3 style="mso-element: footnote">
<P><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"><A name=[3]><A style="mso-footnote-id: ftn3" href="#.[3]" name=_ftn3><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[3]</SPAN></SPAN></A><A style="mso-footnote-id: ftn3" href="#.[3]" name=_ftn3></A></SPAN></SPAN></A> In determining the weight or volume of the sub-sample, we recommend that you consider the following parameters, among others:<SPAN style="mso-spacerun: yes">&nbsp; </SPAN>sensitivity of the analytical method, performance data from method development and validation work, feed mixability and uniformity data, particle size heterogeneity in feeds (e.g., complete feeds with intact grains or roughage), drug concentration, sample size for grinding/homogenization procedures, etc.<SPAN style="mso-spacerun: yes">&nbsp; </SPAN></P></DIV>
<DIV id=ftn4 style="mso-element: footnote">
<P><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"><A name=[4]><A style="mso-footnote-id: ftn4" href="#.[4]" name=_ftn4><SPAN style="mso-special-character: footnote"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA">[4]</SPAN></SPAN></A><A style="mso-footnote-id: ftn4" href="#.[4]" name=_ftn4></A></SPAN></SPAN></A> We recommend that you use a feed matrix similar in composition and intended for the same animal species, if the specific control feed sample matrix is not available.</P></DIV></DIV>
    <ol>


    </ol>
    <div align="left"> </div>

 
<table cellspacing=2 cellpadding=0 width="100%" bgcolor=#ffffff border=0>
        <tbody> 
        <tr> 
          <td align=middle width=10></td>
              <td valign=center align=middle colspan=5><img height=10 alt="Spacer " src="/cvm/Images/dot_clear.gif" width="100%" border=0></td>
          <td align=middle width=10></td>
        </tr>
        <tr> 
              <td valign=center align=middle colspan=7 height=10><img height=1 
            alt="horizonal rule" src="/cvm/Images/blkpixel.gif" width="100%" border=0></td>
        </tr>
        <tr> 
          <td align=middle width=10></td>
          <td colspan=5> 
            <p align="center" class="footer">
                <!-- | <!-- --><a href="/cvm/index.html">CVM A-Z Index</a>
 | <!-- --><a href="/cvm/contactCVM.html">Contact CVM</a>
 | <!-- --><a href="/cvm/aboutcvm.html">About CVM</a>
 | <!-- --><a href="/cvm/index.html">Site Map</a>
<!-- --><br>
                <!-- | <!-- --><a href="http://www.fda.gov/default.htm">FDA Home Page</a>
 | <!-- --><a href="http://www.fda.gov/search.html">Search FDA Site</a>
 | <!-- --><a href="http://www.fda.gov/opacom/hpchoice.html">FDA A-Z Index</a>
 | <!-- --><a href="http://www.fda.gov/comments.html">Contact FDA</a>
 | <!-- --><a href="http://www.fda.gov/privacy.html">Privacy</a>
 | <!-- --><a href="http://www.fda.gov/accessibility.html">Accessibility</a>
 | <!-- --><a href="http://www.hhs.gov/">HHS Home Page</a>
<!-- --><br>
            </p>
          </td>
          <td align=middle width=10></td>
        </tr>
        <tr> 
          <td align=middle width=10></td>
              <td valign=center align=middle colspan=5><img height=1 alt=" " 
            src="/cvm/Images/dot_clear.gif" width="1" border=0></td>
          <td align=middle 
width=10></td>
        </tr>
        </tbody> 
      </table>
</BODY>
</HTML>